Infectious Disease Update Christopher Belcher MD FAAP Director, Pediatric Infectious Diseases Peyton Manning Children’s Hospital Indianapolis, IN Case #1 • 2 yo girl previously healthy • Presented to ER with fever • Found leukopenia / neutropenia and thrombocytopenia • Moderately ill, no rash, no HSM • A piece of historical information led to the diagnostic test. Case #1 Case #1 – P. falciparum Malaria • • • • • Family had spent a month in Nigeria Claim to have taken antimalarials Parasite burden initially above 3% Was treated with atovaquone / proguanil Received treatment in hospital – defervesced, showed count recovery, and clearance of parasitemia CLOSTRIDIUM DIFFICILE COLITIS Clostridium difficile • Presentation: – Often fever, abd pain, diarrhea - bloody, mucousy – Associated with antibiotic use, abd surgery • Has been held children under 2 do not have the receptor for the toxin – Issue being re-examined • Outcomes – Morbidity - diarrhea, fever, prolonged hospital stay – Toxic megacolon / colectomy Background: Impact • Hospital-acquired, hospital-onset: 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths annually • Hospital-acquired, post-discharge (up to 4 weeks): 50,000 cases, $0.3 billion in excess costs, and 3,000 deaths annually • Nursing home-onset: 263,000 cases, $2.2 billion in excess costs, and 16,500 deaths annually Campbell et al. Infect Control Hosp Epidemiol. 2009:30:523-33. Dubberke et al. Emerg Infect Dis. 2008;14:1031-8. Dubberke et al. Clin Infect Dis. 2008;46:497-504. Elixhauser et al. HCUP Statistical Brief #50. 2008. From: Clostridium difficile Infection in Hospitalized Children in the United States Arch Pediatr Adolesc Med. 2011;165(5):451-457. doi:10.1001/archpediatrics.2010.282 Figure Legend: Trend in Clostridium difficile infection (CDI) in hospitalized children. Date of download: 9/4/2012 Copyright © 2012 American Medical Association. All rights reserved. Clostridium difficile • Since 2005 an increase in resistant, aggressive C. difficile colitis (NAP-1) • Associated with fluoroquinolone resistance and increased toxin production • Incidence 22.5 vs 6 per 1000 admissions in 2004 vs 1997 • 30-day attributable mortality rate was 6.9% vs. 1.5% in 1997 N Engl J Med 2005;353:2433-2449,2503-2505. Risks Factors for Disease • Antibiotics put patients at risk – Adults : fluoroquinolones – Children : penicillins and cephalosporins • Clindamycin resistant strain “J” was more prevalent in 1990s • Risks in children include: cancer and IBD Findings of Children Discharged with C. difficile from pediatric hospitals • • • • • • Increasing trend from 1997 - 2006 20% higher mortality rate 36% more likely to have had a colectomy Increased LOS 4x, charges 2x 11 times more likely to have IBD More likely to be on immunosuppression or antibiotics • UNLIKE adults, no increase in severity Arch Ped Adolesc Med 2011; 165: 451-7 What to do with Infants • C. difficile can be a part of the normal flora in newborns and young infants • 70% can be colonized and asymptomatic • The environment, not maternal transmission seems to be the major factor • After 2 years of age, the gut flora should mimic an adult and it is not normal J . C C. difficile Colonization by Age Up to 13 Years of Age David A. Enoch , Matthew J. Butler , Sumita Pai , Sani H. Aliyu , J. Andreas Karas Clostridium difficile in children: Colonisation and disease Journal of Infection Volume 63, Issue 2 2011 105 - 113 Testing for C. difficile • C difficile culture • C difficile toxin detection: EIA, mouse IP • C difficile molecular methods (PCR) – 027/Nap1/BI • In a study of 5 testing methods – molecular methods detected 35-54% more positive specimens • Only need to order PCR once - ONCE Chapin KC. J Mol Diagn. 2011; 13:395-400 Clostridium difficile Prevention and Treatment • Prevention – Good hygiene – C. difficile spores NOT killed by alcohol – Limit antibiotic use • Treatment – – – – – – – STOP the antibiotics Metronidazole Oral vancomycin Fidaxomicin Nitazoxanide (Alinia) Under study: ramoplanin, CB-183315 Others: po bacitracin, tinidazole, IVIG, cholestyramine, probiotics, fecal enemas Metronidazole Therapy • Can be given iv or po • 30 mg/kg/day divided q 6 hours x 10 days – Maximum 2gm/day • 20% or more may relapse after therapy Vancomycin Therapy • Only given po for C. difficile – Can use capsules (125mg, 250 mg) – or IV solution orally • IV vancomycin does not enter gut • 40 mg/kg/day po divided into 4 doses – Maximum 500mg/dose • The best way to create VRE – Vancomycin resistant enterococci Fidaxomicin • • • • • • Narrow spectrum macrocyclic antibiotic ONLY approved in adults 200mg twice a day for 10 days No more effective than vancomycin Lower relapse rate Orphan drug status for children under 16 Probiotic Therapy • 138 hospitalized adults received probiotics or placebo (Plummer S, et al. Clostridium difficile pilot… Int Microbiol . 2004;7:59-62) – Of those with diarrhea: • 2.9% of probiotic group were C. diff positive • 7.2% of placebo group were C. diff positive • The relapse rate of adults with recurrent C. diff was lower when given probiotics (McFarland LV, et al. A randomized placebo-controlled… JAMA . 1994;271:1913-1918) • Metaanalysis shows benefit for AAD and C. diff with S. boulardii and L. rhamnosus (Am J Gastroenterol 2006;101:812-822) • But data are still mixed and no clear recommendation can be made The Potential for Vaccines • Approaches to Vaccines: – Toxoid Vaccine to toxin A and B • • • • Similar to other toxoid vaccines – tetanus, diphtheria Delivered IM Do produce antibody responses Further in development cycle – Recombinant subunit vaccines • Truncated toxin A and B • Newer in development cycle (Aboudola et al., 2003; Kotloff et al., 2001; Intercell , 2011). http://www.discoverymedicine.com/Dale-N-Gerding/2012/01/25/clostridium-difficile-infection-prevention-biotherapeutics-immunologics-and-vaccines/ Case #2 • • • • 15 year old boy, previously well Developed red scaly lesions L clavicle and arm No relief with hydrocortisone Sent to dermatology for psoriasis Case #2 Case #2 • Biopsy of the lesion revealed: – Blastomyces • We live in the land of Histoplasma • Treated with Itraconazole VACCINE SAFETY Vaccine Safety • CDC email study of 476 families • Concerns included: – 38% - too many shots in one visit – 34% - too many vaccines in 2 years – 32% - vaccines may cause fever – 30% - vaccines may cause autism / neurol – 26% - vaccine ingredients are unsafe – 23% - no safety concerns Health Aff. 2011; 30:61151-9 Vaccine Safety - Who Do Parents Trust • 1500 parents online national survey – 76% said they trust their doctor "a lot” – 26% said they trust other HCP "a lot" – 23% said they trust government experts "a lot" Pediatrics 2011; 127:S107-12 Vaccine Safety - Who Do Parents Trust • Family and friends 67% reported as "somewhat trustworthy" • Parents of children harmed by vaccines 65% reported as "somewhat trustworthy" • Celebrities "somewhat trustworthy" by 24% • Mothers more likely than fathers to report influence by parents of children harmed by vaccines, media, celebrities Vaccine Safety • Institute of Medicine - literature review • Vaccines: MMR, VAR, HepA, HepB, HPV, MCV, DTaP – NO association of MMR vaccine with autism based on scientific literature – NO association of Type I diabetes with MMR or DTaP – NO association of asthma, RAD, Bell's palsy with TIV Institute of Medicine http://www.iom.edu/Reports/2011/ Adverse-Effects-of-Vaccines-Evidence-and-Causality/Report-Brief.aspx Vaccine Safety • The report did find convincing evidence for: – Var association with disseminated varicella and with zoster – MMR vaccine and febrile seizures as well as measles inclusion body encephalitis – Hypersensitivity with: MMR, Var, TIV, HepB, MCV, TT Vaccine Safety • The report did find evidence that favored acceptance for: – HPV and anaphylaxis – MMR and transient arthralgia in females and children • Most other associations - the evidence was inadequate to accept or reject Vaccine Safety - What to Do • US Dept of Health and Human Services Study • 272 new mothers – Given written vaccine safety info and VIS – One of 3 groups: prenatal, 1 wk, 2mo • All groups improved attitude • Preferred info before 2 month visit Pediatrics 2011; 127:S120-6 Vaccine Safety - What to Do • Know what parents are reading and talking about • Listen to parental concerns • Dispel myths and misunderstandings with information • Top down your office MUST believe in vaccination and BE vaccinated Case #3 • • • • 10 day old infant Delivered by NSVD Clinically well Developed a rash Case #3 Case #3 • At this point the correct thing to do is: – Obtain HSV swabs and start acyclovir – Obtain a culture and apply mupirocin – Obtain a dermatology consult • The diagnosis was confirmed as: – Incontinentia pigmenti MISCELLANEOUS INFLUENZA UPDATES 2012-13 Influenza Vaccine Composition • A/California/7/2009 (H1N1) • A/Victoria/361/2011 (H3N2) • B/Wisconsin/1/2010 How to Deal with Egg Allergy MMWR Weekly August 17, 2012 / 61(32);613-618 2012-13 Vaccine for Children <9 MMWR Weekly August 17, 2012 / 61(32);613-618 Quadrivalent Influenza Vaccine • Traditional influenza vaccine is trivalent – containing 2 A strains and one B strain • B strains are usually one of two lineages – Victoria and Yamagata • In the first 10 flu seasons this millennium the lineage in the vaccine did not match what circulated HALF the time! • Thus, putting in two B strains is an attractive strategy for future seasons 2013-14 www.cdc.gov/flu/weekly/ H3N2v Influenza • Most symptomatic cases are typical of seasonal influenza • No evidence of sustained human to human transmission • All isolates contain M gene of 2009 H1N1 strain that increases human transmission • Concern when exposed to pigs (not eating pork) • Our PCR detects as unclassified Influenza Case Count: Detected U.S. Human Infections with H3N2v by State since August 2011 States Reporting H3N2v Hawaii Illinois Indiana Iowa Maine Maryland Michigan Minnesota Ohio Pennsylvania Utah West Virginia Wisconsin Total Cases in 2011 2 3 2 3 2 12 Cases in 2012 1 4 138 12 6 4 107 11 1* 3 20 307 http://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm#table1 Case Count: Detected U.S. Human Infections with H3N2v by State since August 2011 States Reporting H3N2v Hawaii Illinois Indiana Iowa Maine Maryland Michigan Minnesota Ohio Pennsylvania Utah West Virginia Wisconsin Total Cases in 2011 2 3 2 3 2 12 Cases in 2012 1 4 138 12 6 4 107 11 1* 3 20 307 http://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm#table1 Case #4 • A thirteen year old girl previously well • Developed moderately painful nodules on her palms • No systemic symptoms Case #4 Case #4 • Diagnostic considerations include: – Syphilis – Papular purpuric gloves and socks syndrome – Non tuberculous mycobacterium – Enterovirus 71 Case #4 • Diagnostic considerations include: – Syphilis – Papular purpuric gloves and socks syndrome – Non tuberculous mycobacterium – Enterovirus 71 Case #4 ID MISCELLANY PMCH ER E. coli Urine Sensitivities Antibiotic Susceptible Intermediate Resistant AMPICILLIN 80 0 82 51% 31 19% AMPICILLIN/SULBACTAM CEFAZOLIN CEFTRIAXONE NON CSF CIPROFLOXACIN GENTAMICIN NITROFURANTOIN TRIMETHSULFAMETHOXAZOLE 49% 0% 112 69% 19 12% 154 95% 3 2% 5 3% 162 100% 0 0% 0 0% 155 96% 0 0% 7 4% 153 94% 0 0% 9 6% 158 98% 3 2% 1 1% 119 73% 0 0% 43 27% Tuberculosis Testing in Children • Mantoux skin test is the gold standard – 15mm is positive for most over 4 years old – 10mm if they have risk factors (<4 yo, overseas, contact with high risk, medical conditions) – 5mm if they are very high risk (household contact, dz, suppressed) • Interferon gamma release assays – – – – Quantiferon TB or T-SPOT Only require single visit for blood draw No false positives with BCG Unreliable under 5 years old DTaP Vaccine Administration Site • • • • Study of over 230,000 patients 5th dose DTaP (age 4-6) 75% given in the arm 0.4% of children had medically attended local reaction • 47.4 vs 32.1 (arm to leg) reactions / 10,000 • Thus, the leg may be an attractive site. Jackson LA et al. Pediatrics. 2011;127:e581-5876 Rabies Prevention • Virus transmitted in saliva of infected animal – Bats are most common source in IN – Tiny teeth and claws – Exposure considered if bat contact cannot be ruled out in room of sleeping or your individual – ***DON’T let them kill the animal*** • PEP involves: – wound cleaning – rabies immune globulin 20 IU/kg around wound / IM – vaccine - 1ml IM on days 0, 3, 7, 14 • 2009 changed recommendation for PEP vaccine from 5 doses to 4 (got rid of day 28) Pneumococcal Disease in 2011 • Had been seeing 140-180 cases of vaccine preventable invasive pneumococcal disease / year • In 2011 was down to 40 • Likely due to introduction and boosters with PCV13 • Drug resistant S. pneumoniae was not seen at PMCH in 2011 Pneumococcal Meningitis Meant to Gross You Out • Hospital Curtains (Schweizer, ICAAC 2011) – 42% of curtains had VRE – 21% had MRSA – 92% were colonized with a pathogen in 1 week • Ties and lab coats are nasty too! Case #5 • • • • • 6 year old boy Had 1 week of fever, cough Presented with Hb 2.6 Hct 7.8 WBC 1.8 Required transfusion in PICU Found to have a warm reactive antibody Case #5 • Testing was postive for: – Influenza – Adenovirus – Mycoplasma pneumoniae – Parvovirus B19 Case #5 • Testing was postive for: – Influenza – Adenovirus – Mycoplasma pneumoniae – Parvovirus B19 Case #5 Infectious Disease Update Christopher Belcher MD FAAP Director, Pediatric Infectious Diseases Peyton Manning Children’s Hospital Indianapolis, IN